Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cfdp1 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Cfdp1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CFDP1 mRNA | CTD | PMID:22206623 | Cfdp1 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of CFDP1 mRNA | CTD | PMID:17555576 | Cfdp1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cfdp1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CFDP1 mRNA | CTD | PMID:16214954 | Cfdp1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CFDP1 mRNA | CTD | PMID:21570461 | Cfdp1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CFDP1 mRNA | CTD | PMID:15328365 more ... | Cfdp1 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of CFDP1 mRNA | CTD | PMID:30851411 | Cfdp1 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Decitabine affects the expression of CFDP1 mRNA | CTD | PMID:23300844 | Cfdp1 | Rat | aflatoxin B1 | decreases methylation | ISO | CFDP1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CFDP1 promoter | CTD | PMID:30157460 | Cfdp1 | Rat | antirheumatic drug | increases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of CFDP1 mRNA | CTD | PMID:24449571 | Cfdp1 | Rat | aristolochic acid A | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CFDP1 mRNA | CTD | PMID:33212167 | Cfdp1 | Rat | Aroclor 1254 | decreases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CFDP1 mRNA | CTD | PMID:23650126 | Cfdp1 | Rat | atrazine | increases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Atrazine results in increased expression of CFDP1 mRNA | CTD | PMID:22378314 | Cfdp1 | Rat | benzo[a]pyrene | increases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CFDP1 mRNA | CTD | PMID:22228805 | Cfdp1 | Rat | benzo[a]pyrene | increases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CFDP1 mRNA | CTD | PMID:21632981 | Cfdp1 | Rat | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CFDP1 mRNA | CTD | PMID:18164116 | Cfdp1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CFDP1 mRNA | CTD | PMID:25181051 | Cfdp1 | Rat | bisphenol A | decreases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CFDP1 mRNA | CTD | PMID:33221593 | Cfdp1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CFDP1 mRNA | CTD | PMID:30816183 and PMID:32528016 | Cfdp1 | Rat | Brodifacoum | decreases expression | EXP | | 6480464 | bromfenacoum results in decreased expression of CFDP1 protein | CTD | PMID:28903499 | Cfdp1 | Rat | CGP 52608 | multiple interactions | ISO | CFDP1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CFDP1 gene] | CTD | PMID:28238834 | Cfdp1 | Rat | chlorpyrifos | decreases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CFDP1 mRNA | CTD | PMID:37019170 | Cfdp1 | Rat | choline | multiple interactions | ISO | Cfdp1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFDP1 gene | CTD | PMID:20938992 | Cfdp1 | Rat | cisplatin | affects expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Cisplatin affects the expression of CFDP1 mRNA | CTD | PMID:23300844 | Cfdp1 | Rat | copper(II) sulfate | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CFDP1 mRNA | CTD | PMID:19549813 | Cfdp1 | Rat | Cuprizon | multiple interactions | ISO | CFDP1 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Haloperidol] results in decreased expression of CFDP1 protein | CTD | PMID:34122009 | Cfdp1 | Rat | diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of CFDP1 mRNA | CTD | PMID:22546817 | Cfdp1 | Rat | dicrotophos | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CFDP1 mRNA | CTD | PMID:28302478 | Cfdp1 | Rat | dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of CFDP1 mRNA | CTD | PMID:22546817 | Cfdp1 | Rat | diuron | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Diuron results in decreased expression of CFDP1 mRNA | CTD | PMID:35967413 | Cfdp1 | Rat | dorsomorphin | multiple interactions | ISO | CFDP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CFDP1 mRNA | CTD | PMID:27188386 | Cfdp1 | Rat | epoxiconazole | increases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CFDP1 mRNA | CTD | PMID:35436446 | Cfdp1 | Rat | ethanol | affects splicing | ISO | Cfdp1 (Mus musculus) | 6480464 | Ethanol affects the splicing of CFDP1 mRNA | CTD | PMID:30319688 | Cfdp1 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of CFDP1 mRNA | CTD | PMID:30307764 | Cfdp1 | Rat | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of CFDP1 mRNA | CTD | PMID:24136188 | Cfdp1 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CFDP1 mRNA | CTD | PMID:24136188 | Cfdp1 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of CFDP1 mRNA | CTD | PMID:24793618 | Cfdp1 | Rat | folic acid | multiple interactions | ISO | Cfdp1 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | Cfdp1 | Rat | haloperidol | multiple interactions | ISO | CFDP1 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Haloperidol] results in decreased expression of CFDP1 protein | CTD | PMID:34122009 | Cfdp1 | Rat | ivermectin | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CFDP1 protein | CTD | PMID:32959892 | Cfdp1 | Rat | L-methionine | multiple interactions | ISO | Cfdp1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFDP1 gene | CTD | PMID:20938992 | Cfdp1 | Rat | methylmercury chloride | increases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of CFDP1 mRNA | CTD | PMID:28001369 | Cfdp1 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CFDP1 mRNA | CTD | PMID:18164116 | Cfdp1 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CFDP1 mRNA | CTD | PMID:25729387 | Cfdp1 | Rat | paracetamol | increases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CFDP1 mRNA | CTD | PMID:26690555 | Cfdp1 | Rat | pentachlorophenol | increases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of CFDP1 mRNA | CTD | PMID:23892564 | Cfdp1 | Rat | potassium chromate | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CFDP1 mRNA | CTD | PMID:22714537 | Cfdp1 | Rat | rac-lactic acid | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of CFDP1 mRNA | CTD | PMID:30851411 | Cfdp1 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of CFDP1 mRNA | CTD | PMID:19013527 | Cfdp1 | Rat | SB 431542 | multiple interactions | ISO | CFDP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CFDP1 mRNA | CTD | PMID:27188386 | Cfdp1 | Rat | sodium arsenite | decreases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CFDP1 mRNA | CTD | PMID:36209798 | Cfdp1 | Rat | sunitinib | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CFDP1 mRNA | CTD | PMID:31533062 | Cfdp1 | Rat | tamoxifen | affects expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of CFDP1 mRNA | CTD | PMID:17555576 | Cfdp1 | Rat | tetrachloromethane | increases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CFDP1 mRNA | CTD | PMID:31919559 | Cfdp1 | Rat | thiram | decreases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Thiram results in decreased expression of CFDP1 mRNA | CTD | PMID:38568856 | Cfdp1 | Rat | titanium dioxide | increases expression | ISO | Cfdp1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CFDP1 mRNA | CTD | PMID:23131501 | Cfdp1 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CFDP1 mRNA | CTD | PMID:25729387 | Cfdp1 | Rat | trichostatin A | increases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CFDP1 mRNA | CTD | PMID:24935251 | Cfdp1 | Rat | triphenyl phosphate | affects expression | ISO | CFDP1 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CFDP1 mRNA | CTD | PMID:37042841 | Cfdp1 | Rat | valproic acid | affects expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CFDP1 mRNA | CTD | PMID:25979313 | Cfdp1 | Rat | valproic acid | increases expression | ISO | CFDP1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CFDP1 mRNA | CTD | PMID:26272509 | Cfdp1 | Rat | valproic acid | multiple interactions | ISO | CFDP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CFDP1 mRNA | CTD | PMID:27188386 | |